Very exciting news broadcast from CBS about a new breakthrough drug treating the underlying cause of Cystic Fibrosis. Kalydeco has shown promising results in a study of just less than 100 people with a specific Cystic Fibrosis genetic mutation. The Cystic Fibrosis Foundation is very excited about this drug as they believe the data from this study will lead to benefits for all those with CF.
No comments:
Post a Comment